AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

Q: What does CUSIP 00847X104 represent in this 13F holders report?

CUSIP 00847X104 is the security identifier for AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in Q4 2018?

182 institutional investors reported AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share for Q4 2018. Use the holders table for investor-level position and value details.

CUSIP: 00847X104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock, Par Value $0.001 per share
Shares outstanding: 59,431,072
Total 13F shares: 58,006,486
Share change: +1,824,021
Total reported value: $2,674,145,349
Put/Call ratio: 37%
Price per share: $46.11
Number of holders: 182
Value change: +$50,031,635
Number of buys: 91
Number of sells: 90

Quarterly Holders Quick Answers

What is CUSIP 00847X104?
CUSIP 00847X104 identifies AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 00847X104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	15%	8,698,886	$670,858,000	—	30 Sep 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	13%	7,867,379	$606,731,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	7.2%	4,251,439	$327,871,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	5.5%	3,285,842	$253,404,000	—	30 Sep 2018	13F
Capital International Investors	13F	Company	5.2%	3,096,422	$238,796,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.8%	2,830,017	$218,251,000	—	30 Sep 2018	13F
BB BIOTECH AG	13F	Company	3.7%	2,197,931	$169,504,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	2.6%	1,561,981	$120,460,000	—	30 Sep 2018	13F
Clearbridge Investments, LLC	13F	Company	2.5%	1,506,662	$116,194,000	—	30 Sep 2018	13F
Woodford Investment Management Ltd	13F	Company	2.2%	1,317,459	$101,602,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.1%	1,241,315	$95,730,000	—	30 Sep 2018	13F
FIRST TRUST ADVISORS LP	13F	Company	2%	1,162,010	$89,614,000	—	30 Sep 2018	13F
Invesco Ltd.	13F	Company	1.4%	825,746	$63,682,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.2%	714,253	$55,083,000	—	30 Sep 2018	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	1.2%	693,954	$53,517,000	—	30 Sep 2018	13F
BAILLIE GIFFORD & CO	13F	Company	1.1%	670,443	$51,705,000	—	30 Sep 2018	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.1%	648,656	$50,024,000	—	30 Sep 2018	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	1.1%	645,912	$49,813,000	—	30 Sep 2018	13F
Polar Capital LLP	13F	Company	1%	602,342	$46,453,000	—	30 Sep 2018	13F
Casdin Capital, LLC	13F	Company	0.98%	579,776	$44,712,000	—	30 Sep 2018	13F
LORD, ABBETT & CO. LLC	13F	Company	0.84%	496,973	$38,327,000	—	30 Sep 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.83%	493,641	$38,069,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.8%	476,965	$36,783,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.66%	390,674	$30,129,000	—	30 Sep 2018	13F
NORGES BANK	13F	Company	0.62%	366,476	$28,262,000	—	30 Sep 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.59%	351,997	$27,146,000	—	30 Sep 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.59%	348,200	$26,853,000	—	30 Sep 2018	13F
BROWN ADVISORY INC	13F	Company	0.58%	343,777	$26,513,000	—	30 Sep 2018	13F
Neuberger Berman Group LLC	13F	Company	0.58%	343,391	$26,482,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	0.5%	300,000	$23,136,000	—	30 Sep 2018	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.42%	250,423	$19,313,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.41%	245,509	$18,934,000	—	30 Sep 2018	13F
LOOMIS SAYLES & CO L P	13F	Company	0.41%	244,675	$18,869,000	—	30 Sep 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.4%	240,418	$18,541,037	—	30 Sep 2018	13F
Capital Bank & Trust Co	13F	Company	0.4%	238,255	$18,374,000	—	30 Sep 2018	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	0.4%	238,050	$18,358,000	—	30 Sep 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.4%	235,975	$18,198,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.36%	215,292	$16,602,000	—	30 Sep 2018	13F
Marshall Wace North America L.P.	13F	Company	0.36%	211,069	$16,278,000	—	30 Sep 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.35%	208,895	$16,110,000	—	30 Sep 2018	13F
AXA S.A.	13F	Company	0.34%	203,984	$15,731,000	—	30 Sep 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.34%	201,712	$15,556,000	—	30 Sep 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.33%	195,370	$15,067,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.31%	182,731	$14,093,000	—	30 Sep 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.3%	175,700	$13,550,000	—	30 Sep 2018	13F
Handelsbanken Fonder AB	13F	Company	0.29%	173,500	$13,380,000	—	30 Sep 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.28%	166,890	$12,870,000	—	30 Sep 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.27%	158,606	$12,232,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.25%	149,000	$11,491,000	—	30 Sep 2018	13F
Rhenman & Partners Asset Management AB	13F	Company	0.24%	145,428	$11,215,000	—	30 Sep 2018	13F

Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2018

As of 31 Dec 2018, AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,006,486 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., Capital International Investors, BB BIOTECH AG, PRICE T ROWE ASSOCIATES INC /MD/, Woodford Investment Management Ltd, STATE STREET CORP, and Clearbridge Investments, LLC. This page lists 182 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

199

Q4 2018 holders

182

Holder diff

-17

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.